FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA OKs ERX Phase 1 Leptin Trials

FDA authorizes additional Phase 1 studies of ERX Pharmaceuticals ERX1000 to treat obesity.

Human Drugs

Genmab, Seagen BLA on Cervical Cancer Therapy

Genmab and Seagen submit a BLA seeking accelerated approval for tisotumab vedotin, indicated for treating patients with recurrent or metastatic cervic...

Human Drugs

Clarke Pharmaceuticals Marketing Unapproved Drugs Online: FDA

FDA warns Clarke Pharmaceuticals it is marketing unapproved and misbranded new drugs.

Human Drugs

Allergans Botox OKd for Pediatric Bladder Condition

FDA approves Allergans Botox for treating detrusor (bladder muscle) overactivity associated with a neurologic condition in certain pediatric patients ...

Human Drugs

House Democrats Seek Lift on Mifepristone Restriction

A group of Democrats on the House Oversight Committee urge FDA to remove the in-person dispensing requirement for medical abortion drug mifepristone.

Medical Devices

Ava Wearable Fertility Tracker Cleared

FDA clears an Ava 510(k) for its wearable Fertility Tracker to aid women in ovulation prediction and facilitating conception.

Human Drugs

CGMP Violations at Allay Pharmaceuticals

FDA warns Allay Pharmaceuticals about CGMP and other violations in its work as a contractor producing finished drugs.

Biologics

Freeline Therapeutics Modifies Hemophilia B Therapy Plan

Freeline Therapeutics says it has modified its clinical development plan for its adeno-associated virus vector-mediated gene therapy FLT180a program f...

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that include Allay Pharmaceuticals and Ignacio J. Rodriguez.

Medical Devices

FDA Monitoring Covid Ventilator Splitters

FDA says it is monitoring clinical experience with ventilator splitters in situations in which no alternatives for invasive ventilatory support are av...